![(4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-olhydrochloride结构式](https://www.chemsrc.com/caspic/340/112960-16-4.png)
(4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-olhydrochloride结构式
|
常用名 | (4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-olhydrochloride | 英文名 | PD128907 HCl |
|---|---|---|---|---|
| CAS号 | 112960-16-4 | 分子量 | 285.77 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C14H20ClNO3 | 熔点 | 145-153°C | |
| MSDS | 中文版 美版 | 闪点 | N/A |
|
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
J. Pharmacol. Exp. Ther. 275 , 1355, (1995) The present study determined the biochemical and pharmacological effects of PD 128907 [R-(+)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H- [1]benzopyrano[4,3-b]-1,4-oxazin-9-ol], a dopamine (DA) receptor agonist that shows a preference for the human D3 receptor... |
|
|
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers.
J. Med. Chem. 33 , 445-450, (1990) The dopamine agonist profile of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol (16a) and its enantiomers (16b-c) was examined. Racemic 16a exhibited moderate affinity for the dopamine (DA) D2 receptor labeled with the D... |
|
|
Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo.
J. Neurochem. 66 , 2209, (1996) In freely moving rats, the novel, selective dopamine (DA) D3 receptor agonist PD 128,907 dose-dependently [effective dose (ED25) = 0.07 mg/kg, s.c.] reduced dialysate levels of DA in the frontal cortex, a structure innervated by the ventral tegmental area (VT... |